ALTIMMUNE UK LIMITED
Company number 02753142 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£63,267,602
Balance sheet as at 2024-12-31
What it does
The principal activity of the company continued to be that of non-clinical and clinical development of immunotherapy and vaccines.
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 1992-10-05
- Employees
- 2 (2024 accounts)
- Registered office
- Central Square 5th Floor, 29 Wellington Street, Leeds, England, LS1 4DL
- Postcode
- LS1 4DL
- Capital
- 2,092,801 GBP
- Accounts category
- Small
Accounts
- Last made up to
- 2024-12-31
- Next due by
- 2026-12-31
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-05-29
- Next due by
- 2027-06-12
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 1 current · 32 resigned
Contact details
- Website
- http://www.altimmune.com
Previous company names
| Name | Date changed |
|---|---|
| VAXIN UK LIMITED | 2015-09-01 |
| IMMUNE TARGETING SYSTEMS (ITS) LIMITED | 2015-03-11 |
| XOVAX LIMITED | 2003-09-17 |
| NIMSTONE SALES LIMITED | 1993-10-19 |
Previous registered addresses 6
| Address | Changed on |
|---|---|
| LONDON BIOSCIENCE INNOVATION, CENTRE, 2 ROYAL COLLEGE STREET, LONDON, NW1 0NH | 2018-12-19 |
| C/O LONDON BIOSCIENCE, INNOVATION CTR, 2 ROYAL COLLEGE, STREET, LONDON, NW1 0NH | 2007-06-28 |
| 45 MEADWAY DRIVE, WOKING, SURREY, GU21 4TD | 2007-06-11 |
| 20 ROSEBERY CRESCENT, WOKING, SURREY GU22 9BL | 2006-07-12 |
| 52 CASTLEBAR ROAD, EALING, LONDON, W5 2DD | 2004-04-16 |
| RUSKIN HOUSE, 40-41 MUSEUM ST, LONDON, WC1A 1LT | 2003-09-05 |
Among its peers
Top 10%
by shareholders' funds, of 11 similar companies in LS
The oldest of its local peers, trading since 1992.
Competitors Leeds
-
3. RESCON LTD
This company ranks 1 among research and experimental development on biotechnology in Leeds.
The class of 1992
49%
of the 21,839 companies incorporated in 1992 are still active today; 46% have since been dissolved.
A fact about the year, not a forecast for this company.